A neoantigen vaccine generates antitumour immunity in renal cell carcinoma - David A. Braun, MD, PhD, Assistant Professor of Medicine (Medical Oncology), Yale School of Medicine
A phase 3, randomized, placebo-controlled trial of a Janus kinase inhibitor to treat giant cell arteritis - Peter A. Merkel, MD, MPH, Professor of Medicine and Epidemiology; Chief, Division of Rheumatology, University of Pennsylvania
Acuity Prediction in Intensive Care Unit-Mamba (APRICOT-M) - Azra Bihorac, MD, MS FCCN, FASN, Senior Associate Dean of Research and Professor of Medicine, University of Florida College of Medicine
Dietary Patterns, Sodium Reduction, and Blood Pressure in Type 2 Diabetes: The DASH4D Randomized Clinical Trial - Scott Pilla, MD, MHS, Assistant Professor of Medicine, Johns Hopkins University School of Medicine
Impact of the MISSION Act on Quality and Outcomes of Interventional Cardiology and Cardiac Surgery among Veterans -Peter W. Groeneveld, MD, MS, Professor of Medicine, University of Pennsylvania
INSPIRE Improving Empiric Antibiotic Selection for Patients Hospitalized With Abdominal & Skin/Soft Tissue Infections - Shruti Gohil, MD, Assistant Professor and Associate Medical Director of Epidemiology & Infection Prevention, University of California, Irvine
Microglial mechanisms drive amyloid-β clearance in immunized patients with Alzheimer's disease - David M. Gate, PhD, Assistant Professor of Neurology, Northwestern University Feinberg School of Medicine
Phase I Trial of huCART19-IL18 Cells in Patients with Relapsed or Refractory CD19+ Cancers - Jakub Svoboda, MD, Associate Professor of Medicine, University of Pennsylvania
Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL) - Jean Y. Tang, MD, PhD, Professor of Dermatology, Stanford University
Type 2 Diabetes Pharmacotherapy De-Escalation Through AI-Enabled Lifestyle Modifications - Kevin Pantalone, DO, Professor of Medicine, Cleveland Clinic